WallStSmart

Haoxi Health Technology Limited Class A Ordinary Shares (HAO)vsTrade Desk Inc (TTD)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Trade Desk Inc generates 6857% more annual revenue ($2.97B vs $42.68M). TTD leads profitability with a 14.6% profit margin vs -6.5%. TTD earns a higher WallStSmart Score of 56/100 (C).

HAO

Hold

49

out of 100

Grade: D+

Growth: 8.7Profit: 2.0Value: 5.0Quality: 9.0
Piotroski: 4/9Altman Z: 5.80

TTD

Buy

56

out of 100

Grade: C

Growth: 6.0Profit: 6.5Value: 6.3Quality: 6.5
Piotroski: 4/9Altman Z: 1.48

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HAO5 strengths · Avg: 9.8/10
Price/BookValuation
0.0x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
41.2%10/10

Revenue surging 41.2% year-over-year

EPS GrowthGrowth
172.7%10/10

Earnings expanding 172.7% YoY

Altman Z-ScoreHealth
5.8010/10

Safe zone — low bankruptcy risk

Debt/EquityHealth
0.109/10

Conservative balance sheet, low leverage

TTD2 strengths · Avg: 8.5/10
Debt/EquityHealth
0.179/10

Conservative balance sheet, low leverage

PEG RatioValuation
0.878/10

Growing faster than its price suggests

Areas to Watch

HAO4 concerns · Avg: 2.0/10
Market CapQuality
$1.24M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-15.5%2/10

ROE of -15.5% — below average capital efficiency

Free Cash FlowQuality
$-2.27M2/10

Negative free cash flow — burning cash

Profit MarginProfitability
-6.5%1/10

Currently unprofitable

TTD2 concerns · Avg: 2.0/10
EPS GrowthGrowth
-20.0%2/10

Earnings declined 20.0%

Altman Z-ScoreHealth
1.482/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : HAO

The strongest argument for HAO centers on Price/Book, Revenue Growth, EPS Growth. Revenue growth of 41.2% demonstrates continued momentum.

Bull Case : TTD

The strongest argument for TTD centers on Debt/Equity, PEG Ratio. Revenue growth of 11.8% demonstrates continued momentum. PEG of 0.87 suggests the stock is reasonably priced for its growth.

Bear Case : HAO

The primary concerns for HAO are Market Cap, Return on Equity, Free Cash Flow.

Bear Case : TTD

The primary concerns for TTD are EPS Growth, Altman Z-Score.

Key Dynamics to Monitor

HAO profiles as a hypergrowth stock while TTD is a value play — different risk/reward profiles.

TTD carries more volatility with a beta of 1.04 — expect wider price swings.

HAO is growing revenue faster at 41.2% — sustainability is the question.

TTD generates stronger free cash flow (279M), providing more financial flexibility.

Bottom Line

TTD scores higher overall (56/100 vs 49/100) and 11.8% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Haoxi Health Technology Limited Class A Ordinary Shares

COMMUNICATION SERVICES · ADVERTISING AGENCIES · USA

Haoxi Health Technology Limited Class A Ordinary Shares is a pioneering force in the health technology sector, focused on revolutionizing healthcare through innovative, technology-driven solutions. The company harnesses advanced artificial intelligence and data analytics to enhance diagnostic precision, streamline treatment processes, and improve patient management. With a robust commitment to research and development, Haoxi is well-positioned to tackle emerging healthcare challenges, presenting substantial growth opportunities for institutional investors aiming to leverage advancements in this dynamic and rapidly evolving market.

Trade Desk Inc

COMMUNICATION SERVICES · ADVERTISING AGENCIES · USA

Trade Desk, Inc. is a technology company in the United States and internationally. The company is headquartered in Ventura, California.

Want to dig deeper into these stocks?